Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Pegulicianine acetate - Lumicell

Next Previous
Search
Drug Profile

Pegulicianine acetate - Lumicell

Alternative Names: LUM-015; LUMISIGHT; Pegulicianine

Latest Information Update: 07 Oct 2024

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Lumicell
  • Developer Duke University; Lumicell; National Cancer Institute (USA)
  • Class Imaging agents
  • Mechanism of Action Diagnostic imaging enhancers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Registered Breast cancer
  • Phase I/II Colorectal cancer; Oesophageal cancer; Pancreatic cancer
  • Clinical Phase Unknown Brain cancer; Peritoneal cancer; Prostate cancer; Soft tissue sarcoma

Most Recent Events

  • 05 Sep 2024 Lumicell announced its intention to launch Pegulicianine acetate in USA in the fourth quarter of 2024
  • 01 Aug 2024 Clinical phase development in Peritoneal-cancer(Diagnosis); Brain Cancer, Prostate cancer is ongoing in USA (IV, Injection) (Lumicell pipeline, August 2024)
  • 01 Aug 2024 Clinical trials in Soft tissue sarcoma (Diagnosis) in USA (IV), before August 2024 (Lumicell pipeline, August 2024)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top